Filing Details
- Accession Number:
- 0001209191-19-014215
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-27 18:39:35
- Reporting Period:
- 2019-02-25
- Accepted Time:
- 2019-02-27 18:39:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11075 Roselle Street San Diego CA 92121 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-27 | 18,333 | $2.59 | 18,999 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-27 | 1,667 | $9.00 | 20,666 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-27 | 16,200 | $61.91 | 4,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-27 | 3,800 | $62.53 | 666 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Acquisiton | 2019-02-25 | 105,000 | $0.00 | 105,000 | $48.36 |
| Common Stock | Common Stock | Disposition | 2019-02-27 | 18,333 | $0.00 | 18,333 | $2.59 |
| Common Stock | Common Stock | Disposition | 2019-02-27 | 1,667 | $0.00 | 1,667 | $9.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,000 | No | 4 | A | Direct | ||
| 41,667 | 2027-12-01 | No | 4 | M | Direct | |
| 8,333 | 2027-05-17 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2018, in multiple transactions at prices ranging from $61.50 to $62.50.
- The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2018, in multiple transactions at prices ranging from $62.51 to $62.62.
- Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan.
- The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/25/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter
- The expiration date for these options is ten (10) years from the date of grant.
- Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter
- Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter
Billionaire Hedge Funds
